首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

2050428

癌症譜分析與通路：技術與全球市場

Cancer Profiling and Pathways: Technologies and Global Markets

出版日期: 2026年05月19日 | 出版商:

BCC Research | 英文 230 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球癌症分析和通路分析技術市場預計將從 2025 年的 183 億美元成長到 2030 年底的 339 億美元，在 2025 年至 2030 年的預測期內，年複合成長率將達到 13.2%。

預計北美癌症分析和通路技術市場將從 2025 年的 71 億美元成長到 2030 年底的 134 億美元，在 2025 年至 2030 年的預測期內，年複合成長率將達到 13.6%。

歐洲癌症分析和通路技術市場預計將從 2025 年的 45 億美元成長到 2030 年底的 91 億美元，在 2025 年至 2030 年的預測期內，年複合成長率將達到 15%。

調查範圍

本報告分析了癌症譜分析和通路技術的市場趨勢，提供了2024年的數據、2025年的預測數據、至2030年的年複合成長率預測（預測期：2025-2030年）以及區域市場細分。報告的主要內容包括競爭格局分析，涵蓋癌症譜分析和通路技術的當前和未來市場潛力，以及法規環境、促進因素、限制因素和機會。報告還分析了行業領先企業的市場佔有率。

本報告詳細介紹了腫瘤學研究和臨床實踐中使用的癌症譜分析和通路技術，並對其進行了定量分析。報告重點在於能夠對腫瘤（包括基於組織和液態生物檢體的腫瘤）進行分子譜分析的技術平台、工具和服務，並允許在訊號通路和網路層面解讀分析結果。

全球癌症譜分析和通路分析技術市場按產品類型、譜分析類型、技術類型、應用和地區進行細分。

市場細分為北美、歐洲、亞太、南美以及中東和非洲五大區域。在每個區域內，均對美國、加拿大、墨西哥、德國、英國、英國、義大利、西班牙、日本、中國、韓國、澳洲和印度等主要國家進行分析。報告提供市場估算和預測，包括2024年基準年的數據以及2025年至2030年的預測數據。

本報告涵蓋以下市場面向：

癌症譜分析與通路分析技術類型
全球市場規模與細分
抑制因子和促進因子
預測至2030年
市場佔有率、競爭優勢和產業結構。
對全球癌症譜分析和通路技術市場的長期潛在影響

本報告內容

146 個資料表和 48 個補充表
全球癌症譜分析與通路技術市場分析
全球趨勢分析，包括 2022 年至 2024 年的歷史銷售數據（銷售數據）、2025 年的預測以及到 2030 年的年複合成長率預測。
對全球市場的當前市場規模和收入前景進行估計，並按產品類型、輪廓類型、技術、應用和地區進行市場佔有率分析。
有關市場動態、技術進步、法規、前景和宏觀經濟變數的影響的事實和數據。
基於波特五力模型和全球供應鏈分析的見解。
專利綜述，重點介紹已註冊和已公佈的主要專利
產業結構分析，包括公司市場佔有率和排名、產品佈局、策略舉措、併購活動和創業融資前景。
概述永續發展趨勢和ESG進展。重點在於消費者意識，以及主要公司目前的狀況及其ESG風險評估。
全球領先公司的簡介，包括 Illumina 公司、Thermo Fisher Scientific 公司、F. Hoffmann-La Roche 公司、Agilent Technologies 公司和 Exact Sciences 公司。

市場動態
市場促進因素
主要腫瘤類型的全球癌症發生率不斷上升
向精準腫瘤學和生物標記主導醫學轉型
擴大伴隨診斷和分子檢測的保險覆蓋範圍
液態生物檢體、單細胞分析和多體學平台的進展
市場限制因素
高昂的檢測成本和資金限制
與數據整合、標準化和互通性相關的挑戰
分子生物學和生物資訊專業人才短缺
市場機遇
開發綜合基因組和多體學檢測板
拓展微小殘留病灶（MRD）的應用、早期檢測與篩檢。

第4章監管情勢

概述
北美洲
美國（FDA、CMS/CLIA）
歐洲
亞太地區
日本（PMDA/厚生勞動省）
印度（CDSCO、ICMR 和國家指南）
亞太地區的其他監管機構
世界其他地區
拉丁美洲 - 巴西（ANVISA）
中東和非洲

第5章：新興科技與趨勢

概述
超高通量和長讀長定序
單細胞與空間分析技術
高通量蛋白質體學和多重免疫組化/成像平台
管線和臨床分析
重點
管道分析
臨床試驗分析
癌症譜分析與通路技術的臨床試驗

第6章市場區隔分析

細分市場
依產品類型
重點
試劑、試劑盒及耗材
設備和系統
軟體與生物資訊學
按分析類型
重點
基因組分析
轉錄組分析
蛋白質體學分析
表觀表觀基因分析
多體學/整合分析
其他
依技術類型
重點
次世代定序（NGS）
基於PCR的平台
IHC/ISH平台
流式細胞技術及相關細胞儀平台
液態生物檢體平台
其他
透過使用
重點
研究和生物標記發現
治療方案和監測
診斷和篩檢
預後預測與風險分層
其他用途
按地區分類
按地區
重點
北美洲
歐洲
亞太地區
南美洲
中東和非洲

第7章競爭訊息

重點
競爭格局
企業市場占有率分析
戰略分析

第8章癌症譜分析與通路技術市場的永續性：ESG觀點

概述
癌症分析和通路技術市場中的ESG
環境影響
社會影響
對管治的影響
ESG風險評估
結論

第9章附錄

調查方法
來源
簡稱
公司簡介
10X GENOMICS INC.
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
CARIS LIFE SCIENCES
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE LTD.
FOUNDATION MEDICINE INC.
GRAIL INC.
GUARDANT HEALTH INC.
ILLUMINA INC.
NANOSTRING (BRUKER SPATIAL BIOLOGY)
NEOGENOMICS INC.
QIAGEN
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.
癌症分析和通路技術市場中新興企業

簡介目錄圖表

Product Code: BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

The North American market for cancer profiling and pathway technologies is expected to grow from $7.1 billion in 2025 and is projected to reach $13.4 billion by the end of 2030, at a CAGR of 13.6% during the forecast period of 2025 to 2030.

The European market for cancer profiling and pathway technologies is expected to grow from $4.5 billion in 2025 and is projected to reach $9.1 billion by the end of 2030, at a CAGR of 15% during the forecast period of 2025 to 2030.

Report Scope

The current report analyzes market trends in cancer profiling and pathway technologies, providing 2024 data, 2025 estimates, compound annual growth rate (CAGR) projections through 2030 (forecast period: 2025-2030), and regional markets for cancer profiling and pathway technologies. Highlights include the current and future market potential of cancer profiling and pathway technologies, as well as an analysis of the competitive environment, encompassing regulatory scenarios, drivers, restraints, and opportunities. The report also covers market shares of industry leaders.

The report provides detailed information and quantitative analysis on cancer profiling and pathway technologies used in oncology research and clinical practice. The focus is on technological platforms, tools, and services that enable the molecular profiling of tumors (both tissue-based and liquid biopsy-based) and the interpretation of results at the pathway and network levels.

The global cancer profiling and pathway technologies market is segmented by product type, profiling type, technology type, application, and geographic region.

The market is segmented into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Within each region, there is an analysis of major countries, including the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for the base year 2024 with forecasts for 2025 through 2030.

The report addresses the following aspects of the market:

Types of cancer profiling and pathway technologies.
Global market size and segmentation.
Constraints and drivers.
Forecasts through 2030.
Market shares, competitiveness, and industry structure.
Potential long-term impacts on the global cancer profiling and pathway technologies market.

Report Includes

146 data tables and 48 additional tables
An analysis of the global market for cancer profiling and pathways technologies
Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
Estimates of the current market size and revenue prospects for the global market, accompanied by a market share analysis by product type, profiling type, technology, application and region
Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impact of macroeconomic variables
Insights derived from Porter's Five Forces model, as well as global supply chain analyses
Patent review, featuring key granted and published patents
Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the current status and ESG risk ratings of leading companies
Profiles of the leading global companies, including Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., and Exact Sciences Corp.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Macroeconomic Factor Analysis
Healthcare Expenditure
Demographic Shifts and Disease Burden
Impact of U.S. Tariffs (Trade Policy and Supply Chain Risk)

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Rising Global Cancer Incidence Across Major Tumor Types
Shift Toward Precision Oncology and Biomarker-Driven Care
Expansion of Companion Diagnostics and Reimbursement for Molecular Tests
Advances in Liquid Biopsy, Single-Cell, and Multi-Omics Platforms
Market Restraints
High Test Costs and Affordability Constraints
Data Integration, Standardization, and Interoperability Challenges
Shortage of Skilled Molecular and Bioinformatics Expertise
Market Opportunities
Development of Comprehensive Genomic and Multi-Omics Panels
Expansion of MRD, Early Detection, and Screening Applications

Chapter 4 Regulatory Landscape

Overview
North America
U.S. (FDA, CMS/CLIA)
Europe
Asia-Pacific
Japan (PMDA/MHLW)
India (CDSCO, ICMR, and National Guidelines)
Other Asia-Pacific Regulators
Rest of the World
Latin America - Brazil (ANVISA)
Middle East and Africa

Chapter 5 Emerging Technologiesand Developments

Overview
Ultra-High-Throughput and Long-Read Sequencing
Single-Cell and Spatial Profiling Technologies
High-Plex Proteomics and Multiplex IHC/Imaging Platforms
Pipeline and Clinical Analysis
Key Takeaways
Pipeline Analysis
Clinical Trials Analysis
Clinical Trial Studies on Cancer Profiling and Pathway Technologies

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Global Cancer Profiling and Pathway Technologies Market, by Product Type
Key Takeaways
Reagents, Kits, and Consumables
Instruments and Systems
Software and Bioinformatics
Global Cancer Profiling and Pathway Technologies Market, by Profiling Type
Key Takeaways
Genomic Profiling
Transcriptomic Profiling
Proteomic Profiling
Epigenomic Profiling
Multi-Omics/Integrative Profiling
Others
Global Cancer Profiling and Pathway Technologies Market, by Technology Type
Key Takeaways
Next-Generation Sequencing (NGS)
PCR-Based Platforms
IHC/ISH Platforms
Flow Cytometry and Related Cytometric Platforms
Liquid Biopsy Platforms
Others
Global Cancer Profiling and Pathway Technologies Market, by Application
Key Takeaways
Research and Biomarker Discovery
Treatment Selection and Monitoring
Diagnostics and Screening
Prognostics and Risk Stratification
Other Applications
Geographic Breakdown
Global Cancer Profiling and Pathway Technologies Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
The Middle East and Africa

Chapter 7 Competitive Intelligence

Key Takeaways
Competitive Landscape
Company Share Analysis
Strategic Analysis

Chapter 8 Sustainability in Cancer Profiling and Pathway Technologies Market: An ESG Perspective

Overview
ESG in the Cancer Profiling and Pathway Technologies Market
Environmental Impact
Social Impact
Governance Impact
ESG Risk Ratings
Conclusion

Chapter 9 Appendix

Methodology
Sources
Abbreviations
Company Profiles
10X GENOMICS INC.
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
CARIS LIFE SCIENCES
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE LTD.
FOUNDATION MEDICINE INC.
GRAIL INC.
GUARDANT HEALTH INC.
ILLUMINA INC.
NANOSTRING (BRUKER SPATIAL BIOLOGY)
NEOGENOMICS INC.
QIAGEN
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.
Some Emerging Companies in the Cancer Profiling and Pathway Technologies Market

簡介目錄圖表

List of Tables

Summary Table : Global Market for Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 1 : List of Selected Clinical Trials Studies on Cancer Profiling and Pathway Technologies, 2020-2025
Table 2 : Global Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 3 : Global Market for Reagents, Kits, and Consumables in Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 4 : Global Market for Instruments and Systems in Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 5 : Global Market for Software and Bioinformatics in Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 6 : Global Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 7 : Global Market for Cancer Profiling and Pathway Technologies in Genomic Profiling, by Region, Through 2030
Table 8 : Global Market for Cancer Profiling and Pathway Technologies in Transcriptomic Profiling, by Region, Through 2030
Table 9 : Global Market for Cancer Profiling and Pathway Technologies in Proteomic Profiling, by Region, Through 2030
Table 10 : Global Market for Cancer Profiling and Pathway Technologies in Epigenomic Profiling, by Region, Through 2030
Table 11 : Global Market for Cancer Profiling and Pathway Technologies in Multi-Omics / Integrative Profiling, by Region, Through 2030
Table 12 : Global Market for Cancer Profiling and Pathway Technologies in Othersby Region, Through 2030
Table 13 : Global Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 14 : Global Market for Cancer Profiling and Pathway Technologies in Next-Generation Sequencing (NGS), by Region, Through 2030
Table 15 : Global Market for Cancer Profiling and Pathway Technologies in PCR-based Platforms, by Region, Through 2030
Table 16 : Global Market for Cancer Profiling and Pathway Technologies in IHC/ISH Platforms, by Region, Through 2030
Table 17 : Global Market for Cancer Profiling and Pathway Technologies in Flow Cytometry and Related Cytometric Platforms, by Region, Through 2030
Table 18 : Global Market for Cancer Profiling and Pathway Technologies in Liquid Biopsy Platforms, by Region, Through 2030
Table 19 : Global Market for Cancer Profiling and Pathway Technologies in Other Technology, by Region, Through 2030
Table 20 : Global Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 21 : Global Market for Cancer Profiling and Pathway Technologies in Research and Biomarker Discovery, by Region, Through 2030
Table 22 : Global Market for Cancer Profiling and Pathway Technologies in Treatment Selection and Monitoring, by Region, Through 2030
Table 23 : Global Market for Cancer Profiling and Pathway Technologies in Diagnostics and Screening, by Region, Through 2030
Table 24 : Global Market for Cancer Profiling and Pathway Technologies in Prognostics and Risk Stratification, by Region, Through 2030
Table 25 : Global Market for Cancer Profiling and Pathway Technologies in Other Applications, by Region, Through 2030
Table 26 : Global Market for Cancer Profiling and Pathway Technologies, by Region, Through 2030
Table 27 : North American Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 28 : North American Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 29 : North American Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 30 : North American Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 31 : North American Market for Cancer Profiling and Pathway Technologies, by Country, Through 2030
Table 32 : U.S. Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 33 : U.S. Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 34 : U.S. Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 35 : U.S. Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 36 : Canadian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 37 : Canadian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 38 : Canadian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 39 : Canadian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 40 : Mexican Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 41 : Mexican Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 42 : Mexican Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 43 : Mexican Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 44 : European Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 45 : European Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 46 : European Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 47 : European Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 48 : European Market for Cancer Profiling and Pathway Technologies, by Country, Through 2030
Table 49 : German Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 50 : German Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 51 : German Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 52 : German Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 53 : U.K. Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 54 : U.K. Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 55 : U.K. Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 56 : U.K. Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 57 : French Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 58 : French Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 59 : French Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 60 : French Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 61 : Italian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 62 : Italian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 63 : Italian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 64 : Italian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 65 : Spanish Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 66 : Spanish Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 67 : Spanish Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 68 : Spanish Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 69 : Rest of Europe Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 70 : Rest of Europe Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 71 : Rest of Europe Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 72 : Rest of Europe Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 73 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 74 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 75 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 76 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 77 : Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Country, Through 2030
Table 78 : Chinese Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 79 : Chinese Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 80 : Chinese Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 81 : Chinese Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 82 : Japanese Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 83 : Japanese Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 84 : Japanese Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 85 : Japanese Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 86 : Indian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 87 : Indian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 88 : Indian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 89 : Indian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 90 : South Korean Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 91 : South Korean Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 92 : South Korean Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 93 : South Korean Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 94 : Australian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 95 : Australian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 96 : Australian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 97 : Australian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 98 : Rest of Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 99 : Rest of Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 100 : Rest of Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 101 : Rest of Asia-Pacific Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 102 : South American Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 103 : South American Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 104 : South American Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 105 : South American Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 106 : South American Market for Cancer Profiling and Pathway Technologies, by Country, Through 2030
Table 107 : Brazilian Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 108 : Brazilian Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 109 : Brazilian Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 110 : Brazilian Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 111 : Argentine Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 112 : Argentine Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 113 : Argentine Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 114 : Argentine Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 115 : Rest of South America Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 116 : Rest of South America Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 117 : Rest of South America Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 118 : Rest of South America Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 119 : MEA Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 120 : MEA Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 121 : MEA Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 122 : MEA Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 123 : MEA Market for Cancer Profiling and Pathway Technologies, by Sub-region, Through 2030
Table 124 : Middle East Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 125 : Middle East Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 126 : Middle East Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 127 : Middle East Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 128 : African Market for Cancer Profiling and Pathway Technologies, by Product Type, Through 2030
Table 129 : African Market for Cancer Profiling and Pathway Technologies, by Profiling Type, Through 2030
Table 130 : African Market for Cancer Profiling and Pathway Technologies, by Technology Type, Through 2030
Table 131 : African Market for Cancer Profiling and Pathway Technologies, by Application, Through 2030
Table 132 : Strategic Initiatives in the Global Cancer Profiling and Pathway Technologies Market, 2024-2025
Table 133 : ESG Rankings for Leading Companies in the Cancer Profiling and Pathway Technologies Market, 2025*
Table 134 : Information Sources for this Report
Table 135 : Abbreviations Used in the Cancer Profiling and Pathway Technologies Market Report
Table 136 : 10X Genomics Inc.: Company Snapshot
Table 137 : 10X Genomics Inc.: Financial Performance, FY 2023 and 2024
Table 138 : 10X Genomics Inc.: Product Portfolio
Table 139 : 10X Genomics Inc.: News/Key Developments, 2022-2025
Table 140 : Agilent Technologies Inc.: Company Snapshot
Table 141 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 142 : Agilent Technologies Inc.: Product Portfolio
Table 143 : Agilent Technologies Inc.: News/Key Developments, 2023-2025
Table 144 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 145 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 146 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 147 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024-2025
Table 148 : Caris Life Sciences: Company Snapshot
Table 149 : Caris Life Sciences: Product Portfolio
Table 150 : Caris Life Sciences: News/Key Developments, 2022-2024
Table 151 : Exact Sciences Corp.: Company Snapshot
Table 152 : Exact Sciences Corp.: Financial Performance, FY 2023 and 2024
Table 153 : Exact Sciences Corp.: Product Portfolio
Table 154 : Exact Sciences Corp.: News/Key Developments, 2022-2025
Table 155 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 156 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 157 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 158 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024-2025
Table 159 : Foundation Medicine Inc.: Company Snapshot
Table 160 : Foundation Medicine Inc.: Product Portfolio
Table 161 : Foundation Medicine Inc.: News/Key Developments, 2022-2025
Table 162 : Grail Inc.: Company Snapshot
Table 163 : Grail Inc.: Financial Performance, FY 2023 and 2024
Table 164 : Grail Inc.: Product Portfolio
Table 165 : Grail Inc.: News/Key Developments, 2024-2025
Table 166 : Guardant Health Inc.: Company Snapshot
Table 167 : Guardant Health Inc.: Financial Performance, FY 2023 and 2024
Table 168 : Guardant Health Inc.: Product Portfolio
Table 169 : Guardant Health Inc.: News/Key Developments, 2022-2025
Table 170 : Illumina Inc.: Company Snapshot
Table 171 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 172 : Illumina Inc.: Product Portfolio
Table 173 : Illumina Inc.: News/Key Developments, 2023-2025
Table 174 : Nanostring (Bruker Spatial Biology): Company Snapshot
Table 175 : Nanostring (Bruker Spatial Biology): Product Portfolio
Table 176 : Nanostring (Bruker Spatial Biology): News/Key Developments, 2024
Table 177 : Neogenomics Inc.: Company Snapshot
Table 178 : Neogenomics Inc.: Financial Performance, FY 2023 and 2024
Table 179 : Neogenomics Inc.: Product Portfolio
Table 180 : Neogenomics Inc.: News/Key Developments, 2025
Table 181 : Qiagen: Company Snapshot
Table 182 : Qiagen: Financial Performance, FY 2023 and 2024
Table 183 : Qiagen: Product Portfolio
Table 184 : Qiagen: News/Key Developments, 2022-2025
Table 185 : Sysmex Corp.: Company Snapshot
Table 186 : Sysmex Corp.: Financial Performance, FY 2023 and 2024
Table 187 : Sysmex Corp.: Product Portfolio
Table 188 : Sysmex Corp.: News/Key Developments, 2024-2025
Table 189 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 190 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 191 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 192 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2025
Table 193 : Few Emerging Companies in the Cancer Profiling and Pathway Technologies Market

List of Figures

Summary Figure : Global Market Shares for Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 1 : Porter's Five Forces Analysis of the Cancer Profiling and Pathway Technologies Market
Figure 2 : Global Health Expenditures, 2018-2024
Figure 3 : U.S. Health Expenditure Trend, 2019-2023
Figure 4 : Global Cancer Burden and Projections, 2022-2050
Figure 5 : Market Dynamics of Cancer Profiling and Pathway Technologies
Figure 6 : Global Cancer Burden and Projections, 2022-2050
Figure 7 : Estimated New Cancer Cases and Deaths in the U.S., 2024
Figure 8 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 9 : Global Market Shares for Reagents, Kits, and Consumables in Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 10 : Global Market Shares for Instruments and Systems in Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 11 : Global Market Shares for Software and Bioinformatics in Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 12 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 13 : Global Market Shares for Cancer Profiling and Pathway Technologies in Genomic Profiling, by Region, 2024
Figure 14 : Global Market Shares for Cancer Profiling and Pathway Technologies in Transcriptomic Profiling, by Region, 2024
Figure 15 : Global Market Shares for Cancer Profiling and Pathway Technologies in Proteomic Profiling, by Region, 2024
Figure 16 : Global Market Shares for Cancer Profiling and Pathway Technologies in Epigenomic Profiling, by Region, 2024
Figure 17 : Global Market Shares for Cancer Profiling and Pathway Technologies in Multi-omics/Integrative Profiling, by Region, 2024
Figure 18 : Global Market Shares for Cancer Profiling and Pathway Technologies in Others, by Region, 2024
Figure 19 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 20 : Global Market Shares for Cancer Profiling and Pathway Technologies in Next-generation Sequencing (NGS), by Region, 2024
Figure 21 : Global Market Shares for Cancer Profiling and Pathway Technologies in PCR-Based Platforms, by Region, 2024
Figure 22 : Global Market Shares for Cancer Profiling and Pathway Technologies in IHC/ISH Platforms, by Region, 2024
Figure 23 : Global Market Shares for Cancer Profiling and Pathway Technologies in Flow Cytometry and Related Cytometric Platforms, by Region, 2024
Figure 24 : Global Market Shares for Cancer Profiling and Pathway Technologies in Liquid Biopsy Platforms, by Region, 2024
Figure 25 : Global Market Shares for Cancer Profiling and Pathway Technologies in Other Technology, by Region, 2024
Figure 26 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 27 : Global Market Shares for Cancer Profiling and Pathway Technologies in Research and Biomarker Discovery, by Region, 2024
Figure 28 : Global Market Shares for Cancer Profiling and Pathway Technologies in Treatment Selection and Monitoring, by Region, 2024
Figure 29 : Global Market Shares for Cancer Profiling and Pathway Technologies in Diagnostics and Screening, by Region, 2024
Figure 30 : Global Market Shares for Cancer Profiling and Pathway Technologies in Prognostics and Risk Stratification, by Region, 2024
Figure 31 : Global Market Shares for Cancer Profiling and Pathway Technologies in Other Applications, by Region, 2024
Figure 32 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Region, 2024
Figure 33 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 34 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 35 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 36 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 37 : North American Market Shares for Cancer Profiling and Pathway Technologies, by Country, 2024
Figure 38 : European Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 39 : European Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 40 : European Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 41 : European Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 42 : European Market Shares for Cancer Profiling and Pathway Technologies, by Country, 2024
Figure 43 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 44 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 45 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 46 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 47 : Asia-Pacific Market Shares for Cancer Profiling and Pathway Technologies, by Country, 2024
Figure 48 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 49 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 50 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 51 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 52 : South American Market Shares for Cancer Profiling and Pathway Technologies, by Country, 2024
Figure 53 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Product Type, 2024
Figure 54 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Profiling Type, 2024
Figure 55 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Technology Type, 2024
Figure 56 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Application, 2024
Figure 57 : MEA Market Shares for Cancer Profiling and Pathway Technologies, by Sub-region, 2024
Figure 58 : Global Market Shares for Cancer Profiling and Pathway Technologies, by Company, 2024
Figure 59 : Advantages of ESG for Companies
Figure 60 : 10X Genomics Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 61 : 10X Genomics Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 62 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 63 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 64 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 65 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 66 : Exact Sciences Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 67 : Exact Sciences Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 68 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 69 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 70 : Grail Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 71 : Grail Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 72 : Guardant Health Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 73 : Guardant Health Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 74 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 75 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 76 : Qiagen: Revenue Shares, by Business Unit, FY 2024
Figure 77 : Qiagen: Revenue Shares, by Country/Region, FY 2024
Figure 78 : Sysmex Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 79 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 80 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024